Related Experiment Video
Updated: Jul 7, 2026

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions
Published on: October 18, 2017
Lethal metabolism of Candida albicans respiratory mutants
D Lucas Kane1, Brendan Burke2, Monica Diaz2
1Department of Chemistry and Medicinal Chemistry Shared Resource, Georgetown University, Washington, DC, United States of America.
Abstract:
The destructive impact of fungi in agriculture and animal and human health, coincident with increases in antifungal resistance, underscores the need for new and alternative drug targets to counteract these trends. Cellular metabolism relies on many intermediates with intrinsic toxicity and promiscuous enzymatic activity generates others. Fuller knowledge of these toxic entities and their generation may offer opportunities of antifungal development. From this perspective our observation of media-conditional lethal metabolism in respiratory mutants of the opportunistic fungal pathogen Candida albicans was of interest. C. albicans mutants defective in NADH:ubiquinone oxidoreductase (Complex I of the electron transport chain) exhibit normal growth in synthetic complete medium. In YPD medium, however, the mutants grow normally until early stationary phase whereupon a dramatic loss of viability occurs. Upwards of 90% of cells die over the subsequent four to six hours with a loss of membrane integrity. The extent of cell death was proportional to the amount of BactoPeptone, and to a lesser extent, the amount of yeast extract. YPD medium conditioned by growth of the mutant was toxic to wild-type cells indicating mutant metabolism established a toxic milieu in the media. Conditioned media contained a volatile component that contributed to toxicity, but only in the presence of a component of BactoPeptone. Fractionation experiments revealed purine nucleosides or bases as the synergistic component. GC-mass spectrometry analysis revealed acetal (1,1-diethoxyethane) as the active volatile. This previously unreported and lethal synergistic interaction of acetal and purines suggests a hitherto unrecognized toxic metabolism potentially exploitable in the search for antifungal targets.
Insights
New research reveals a lethal interaction between acetal and purines in Candida albicans metabolism. This finding offers potential new antifungal drug targets to combat rising antifungal resistance.
Area of Science:
- Mycology
- Biochemistry
- Medical Microbiology
Background:
- Fungal infections pose significant threats to agriculture, animal, and human health.
- Increasing antifungal resistance necessitates novel drug targets and therapeutic strategies.
- Understanding toxic metabolic byproducts can inform antifungal development.
Purpose of the Study:
- To investigate media-conditional lethality in respiratory mutants of Candida albicans.
- To identify the toxic factors produced by these mutants.
- To explore novel antifungal targets based on metabolic vulnerabilities.
Main Methods:
- Culturing Candida albicans mutants defective in NADH:ubiquinone oxidoreductase (Complex I).
- Assessing cell viability in different media (synthetic complete vs. YPD) and conditioned media.
- Utilizing GC-mass spectrometry for chemical analysis of toxic components.
- Conducting fractionation experiments to identify synergistic factors.
Main Results:
- Complex I mutants exhibit normal growth in synthetic complete medium but undergo rapid cell death in YPD medium.
- Cell death in YPD medium is dependent on BactoPeptone and yeast extract concentration.
- Mutant-conditioned YPD medium is toxic to wild-type cells, indicating the production of a toxic milieu.
- A lethal synergistic interaction was identified between acetal (a volatile compound) and purines (from BactoPeptone).
Conclusions:
- Candida albicans Complex I mutants generate a toxic metabolic byproduct in specific media conditions.
- The synergistic toxicity of acetal and purines represents a previously unrecognized metabolic pathway.
- This pathway presents a potential new target for antifungal drug development to combat resistant fungal infections.
More Related Videos
08:48Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
09:24Use of In Vivo Imaging to Screen for Morphogenesis Phenotypes in Candida albicans Mutant Strains During Active Infection in a Mammalian Host
Published on: October 12, 2022